SARS-CoV-2 viral shedding in vaccinated and unvaccinated persons: A case series.
COVID-19 vaccines
Prisons
SARS-CoV-2
Virus shedding
Journal
Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899
Informations de publication
Date de publication:
10 03 2023
10 03 2023
Historique:
received:
02
09
2022
revised:
09
11
2022
accepted:
14
11
2022
pubmed:
27
11
2022
medline:
7
3
2023
entrez:
26
11
2022
Statut:
ppublish
Résumé
The preclinical time course of SARS-CoV-2 shedding is not well-described. Understanding this time course will help to inform risk of SARS-CoV-2 transmission. During an outbreak in a congregate setting, we collected paired mid-turbinate nasal swabs for antigen testing and reverse-transcription polymerase chain reaction (RT-PCR) every other day from all consenting infected and exposed persons. Among 12 persons tested prospectively before and during SARS-CoV-2 infection, ten of 12 participants (83%) had completed a primary COVID-19 vaccination series prior to the outbreak. We recovered SARS-CoV-2 in viral culture from 9/12 (75%) of participants. All three persons from whom we did not recover SARS-CoV-2 in viral culture had completed their primary vaccination series. We recovered SARS-CoV-2 from viral culture in 6/9 vaccinated persons and before symptom onset in 3/6 symptomatic persons. These findings underscore the need for both non-pharmaceutical interventions and vaccination to mitigate transmission.
Identifiants
pubmed: 36435706
pii: S0264-410X(22)01428-1
doi: 10.1016/j.vaccine.2022.11.030
pmc: PMC9671797
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1769-1773Informations de copyright
Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1139-1143
pubmed: 32817597
Microbiol Spectr. 2022 Feb 23;10(1):e0153221
pubmed: 34985301
Emerg Infect Dis. 2020 Jun;26(6):1266-1273
pubmed: 32160149
J Infect Chemother. 2022 Feb;28(2):347-351
pubmed: 34774431
Emerg Infect Dis. 2021 Feb;27(2):352-359
pubmed: 33275874
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794447
J Infect Dis. 2021 Sep 1;224(5):771-776
pubmed: 33693830
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
BMC Infect Dis. 2021 Dec 27;21(1):1282
pubmed: 34961470
Nat Med. 2022 Jul;28(7):1491-1500
pubmed: 35395151